Skip to content
Independent Medical Alliance
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate
  • My Accountmy account
  • Home
    Latest Updates

    Stay up-to-date with the latest news from our fast-moving field.

    View
    Blog

    Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from IMA.

    Read Now
    In the News

    Read media coverage of IMA from around the world.

    View
  • TREATMENT
    Treatment Guidelines

    Strategies to prevent and treat COVID-19, Long COVID, RSV, Flu and Vaccine-related issues:

    • Prevention
    • Treatment
    • Long COVID Recovery
    • Vaccine Injury Prevention
    • Shedding from Vaccines
    • Long Vax Recovery

    Strategies to prevent and treat conditions like cancer, depression, insulin resistance and more:

    • Brain Health
    • Cancer Resource Hub
    • Depression & Mental Health
    • Fasting & Healthy Eating
    • Insulin Resistance
    • Sepsis
  • Resources
    Wondering where to begin?

    Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

    get started
    Patient Resources
    • Find a Provider
    • Find a Pharmacy
    • Tools & Guides
    • Testimonials
    • FAQ
    Professional Resources
    • Journal of Independent Medicine

    • Research
    • Ivermectin Facts
    • Informed Consent
    • Join the Alliance
  • Education
    About the education portal

    IMA’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

    Education on Demand

    Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from IMA (formerly FLCCC) educational programs.

    • My Content
    • Explore Courses
  • Community
    Events

    IMA hosts dynamic events that unite top experts from diverse fields for learning, sharing, and collaboration. Join us for unique in-person and virtual experiences that foster knowledge exchange and meaningful partnerships.

    • Weekly Webinar

    • Annual Conference
    Forums

    Join the discussion! IMA public and private forums are a place for the IMA community to connect without fear of censorship.

    • Forums
    Membership

    Explore IMA (formerly FLCCC) membership options for healthcare professionals and committed individuals who share a common passion and purpose. Members receive access to private forums and exclusive content and events while supporting IMA’s mission.

    • Join Now
    • Sign In
  • About
    About the IMA

    Learn about the history of IMA (formerly FLCCC), our mission and vision, and how you can get involved.

    learn more
    • Founders & Clinical Team
    • Senior Fellows
    • Contributors
    • Partners
    • Connect with Us
    • Advocacy
    • Impact Reports
    • Annual Reports
    • Support Us
    • Shop our Store
  • Search
    Search for:
  • IMA HOME
    • Latest UpdatesGet the latest updates from the FLCCC Alliance and their work on COVID-19 prevention and treatment.
    • Blog
    • In the NewsCheck out the latest in news coverage focused on the FLCCC Alliance and our members!
  • TREATMENT
    • Prevention
    • Treatment
    • Recovery
    • More Protocols
      • Brain Health
      • Cancer Resource Hub
      • Depression & Mental Health
      • Eat Well
      • Insulin Resistance
      • Sepsis Care
      • Shedding from Vaccines
  • RESOURCES
    • Journal of Independent Medicine
    • Research
    • Tools & Guides
    • Find a Provider
    • Find a Pharmacy
    • FAQ
    • Efficacy of Ivermectin
    • Join The Alliance
  • EDUCATION
    • Courses
  • COMMUNITY
    • Events
      • Annual Conference 2026
      • Weekly WebinarsJoin FLCCC’s live webinars every Wednesday at 7 pm ET for the latest updates on COVID news & treatment options. Hear from experts, get questions answered!
    • Forums
    • Membership
  • ABOUT
    • Founders & Clinical Team
    • Senior Fellows
    • IMA Contributors
    • Partners
    • Annual Reports
    • Impact Reports
    • Connect with Us
Independent Medical Alliance
  • MY ACCOUNT
  • MY FORUMS
  • MY COURSES
Search for:
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate

References

Categories

Cancer Care (474) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (13) Antidepressants (9) Ascorbic Acid (13) autoantibodies (10) autophagy (48) Breast Cancer (30) Cancer (69) Cancer Stem Cells (11) Chemotherapy (12) Colon Cancer (11) Corticosteroids (9) COVID-19 (330) COVID-19 Vaccines (8) Curcumin (14) Cytokines (13) Depression (12) Diabetes (14) Famotidine (14) Hydroxychloroquine (15) Hyperbaric Oxygen Therapy (9) Inflammation (15) intermittent fasting (14) ivermectin (53) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Pneumonia (9) quercetin (15) resveratrol (11) SARS-CoV-2 (83) Sepsis (22) spermidine (11) Spike Protein (12) Thiamine (11) Thrombosis (9) Tinnitus (12) Tumor (41) Vitamin C (30) Vitamin D (29) Zinc (12)
  • Reference: Ivermectin for the prevention and treatment of COVID-19 infection: a systematic review and meta-analysis.

    Published On: June 21, 2021

    Authors: Bryant A, Lawrie TA, Dowswell T, Fordham E, Mitchell S, Hill SR et al. PMID: 34145166 PMCID: PMC8248252 DOI: 10.1097/MJT.0000000000001402 Abstract Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Areas of uncertainty: We assessed the [...]

    Categories: I-CARE Early Covid, MATH+

    Tags: COVID-19, ivermectin

  • Reference: Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial.

    Published On: June 19, 2021

    Authors: Ahmadi R, Salari S, Reihani H, Eslami S. PMID: PMC8358331 DOI: 10.1002/fsn3.2226 Abstract Background: Curcumin, a natural polyphenolic compound, is proposed as a potential treatment option for patients with coronavirus disease by inhibiting the entry of virus to the cell, encapsulation of the virus and viral protease, as well as modulating various cellular signaling [...]

    Categories: I-CARE Early Covid, I-PREVENT, I-RECOVER Post-Vaccine

    Tags: COVID-19, Curcumin

  • Reference: Telmisartan for treatment of COVID-19 patients: an open multicenter randomized clinical trial.

    Published On: June 18, 2021

    Authors: Duarte M, Pelorosso F, Nicolosi L, Salgado V, Vetulli H PMID: 34189447 PMCID: PMC8225700 DOI: 10.1016/j.eclinm.2021.100962 Abstract Background: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. Methods: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patients from 18 [...]

    Categories: I-CARE Early Covid, MATH+

    Tags: COVID-19, telmisartan

  • Reference: Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentraion (ACTION): an open-label, multicentre, randomised, controlled trial.

    Published On: June 12, 2021

    Authors: Lopes RD, Furtado RH, Bronhara B, Damiani LP, Barbosa LM. DOI:https://doi.org/10.1016/S0140-6736(21)01203-4 Abstract Background COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the efficacy and safety of therapeutic versus prophylactic anticoagulation in this population. Methods [...]

    Categories: MATH+

    Tags: Anticoagulant, COVID-19

  • Reference: Decoding molnupiravir-induced mutagenesis in SARS-CoV-2.

    Published On: June 9, 2021

    Authors: Menendez-Arias L PMID: 34118236 PMCID: PMC8188802 DOI: 10.1016/j.jbc.2021.100867 Abstract Molnupiravir, a prodrug of the nucleoside derivative β-D-N4-hydroxycytidine (NHC), is currently in clinical trials for COVID-19 therapy. However, the biochemical mechanisms involved in molnupiravir-induced mutagenesis had not been explored. In a recent study, Gordon et al. demonstrated that NHC can be incorporated into viral RNA [...]

    Categories: I-CARE Early Covid

    Tags: COVID-19, molnupiravir, SARS-CoV-2

  • Reference: Possible therapeutic effects of adjuvant Quercetin supplementation against early stage COVID-19 infection:A prospective, randomized, controlled, and open-label study.

    Published On: June 8, 2021

    Authors: DiPierro F, Derosa G, Maffioli P, Togni S, Riva A PMID: 34135619 PMCID: PMC8197660 DOI: 10.2147/IJGM.S318720 Abstract Background: Quercetin, a well-known naturally occurring polyphenol, has recently been shown by molecular docking, in vitro and in vivo studies to be a possible anti-COVID-19 candidate. Quercetin has strong antioxidant, anti-inflammatory, immunomodulatory, and antiviral properties, and it [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: COVID-19, quercetin

  • Reference: Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.

    Published On: June 2, 2021

    Authors: Cuesta-Llavona E, Gomez J, Albaiceta GM, Amado-Rodriguez L, Garcia-Clemente M PMID: 34116286 PMCID: PMC8169316 DOI: 10.1016/j.intimp.2021.107825 Abstract The chemokine receptor CCR5 has been implicated in COVID-19. CCR5 and its ligands are overexpressed in patients. The pharmacological targeting of CCR5 would improve the COVID-19 severity. We sought to investigate the role of the CCR5-Δ32 variant [...]

    Categories: I-RECOVER Long Covid

    Tags: CCR5, COVID-19

  • Reference: COVID-19 spreading across world correlates with C677T allele of the methelenetetarhydrofolate reductase (MTHFR) geneprevalence.

    Published On: June 1, 2021

    Authors: Pont G, Pastorino L, Manfredini M, Ozben T, Oliva G, Kaleci S PMID: 34061414 PMCID: PMC8209953 DOI: 10.1002/jcla.23798 Abstract Background: Homocysteine assessment has been proposed as a potential predictive biomarker for the severity of COVID-19 infection. The purpose of this review was to analyze the correlation between the prevalence of MTHFR C677 T gene [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: COVID-19, MTHFR

  • Reference: Plasmapheresis efficiency in Coronavirus disease 2019: More related to what you add and not what you take away?

    Published On: June 1, 2021

    Authors: Jamme M, Mazeraud A PMID: 33769769 DOI: 10.1097/CCM.0000000000004926 Abstract We have read with a great interest the study by Fernandez et al (1) published in a recent issue of Critical Care Medicine. In this case-series, the authors reported the outcome of four patients admitted in ICU with coronavirus disease 2019 (COVID-19) complicated with multiorgan [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: COVID-19, Plasmapheresis

  • Reference: Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.

    Published On: May 25, 2021

    Authors: Chen T, Song J, Liu H, Zheng H, Chen C PMID: 34035353 PMCID: PMC8149409 DOI: 10.1038/s41598-021-90351-y Abstract The objective of this study was to detect the Epstein-Barr virus (EBV) coinfection in coronavirus disease 2019 (COVID-19). In this retrospective single-center study, we included 67 COVID-19 patients with onset time within 2 weeks in Renmin Hospital [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: COVID-19

Previous8910Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the IMA
  • Protocols

  • Providers

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us
FLCCC Logo with white letters
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About IMA
  • Protocols
  • Providers
  • Testimonials
  • Latest Updates
  • Newsletter Signup
Support Us
Give Now
shop
Follow Us
Disclaimer

©2020–2025 All Rights Reserved Independent Medical Alliance (IMA), formerly FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. IMA does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “IMA”, I agree and acknowledge that “IMA” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For information on data handling, terms of use, and disclaimers, visit our Privacy Policy & Terms.

© Copyright 2026. Independent Medical Alliance (IMA), formerly FLCCC Alliance.

Page load link
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT

Ask Our Experts

Have a question you don’t see on our list? Complete the form below with a question or topic you’d like our experts to consider adding to our FAQs resource center. Questions will not be answered individually (we cannot provide medical advice or treatment through this form).

Please enable JavaScript in your browser to complete this form.
Opt In
Loading

Disclaimer: We are unable to offer individualized medical advice, diagnoses, or treatment recommendations. For any personal medical decisions, always consult with your own healthcare provider.

Join us at IMA 2026

Join us April 17-18 for IMA 2026, a two-day event in Texas covering the latest innovations, research, and forward-thinking practices shaping the future of healthcare. Earn 12.75 Continuing Education Credits!

Buy Tickets Now

Go to Top